PET-CT When — Cancer Has No Known Source

Cancer of unknown primary means that a biopsy has confirmed cancer is present — usually in a lymph node, the liver, or bone — but thorough investigation has not found the organ where those cancer cells originally grew. It is not a rare situation; it accounts for a small but meaningful share of all new cancer diagnoses. The biopsy can identify what kind of cancer cell is present, and that information shapes treatment even before a primary site is found.

PET-CT finds the primary in some patients, but not all. The likelihood depends on where the spread appeared, what the cancer cells look like under a microscope, and how much earlier CT scanning has already narrowed the search. The strongest evidence is in head and neck presentations — when cancer appears in a neck lymph node with no visible primary in the throat or mouth, PET-CT meaningfully improves detection over CT alone, as described in ESMO guidance. In other presentations the benefit is smaller and less predictable. Your oncologist will tell you honestly what they expect the scan to achieve in your specific situation.

Treatment does not wait indefinitely for a primary to be identified. NCCN and ESMO both describe treatment pathways for cancer of unknown primary as a distinct, manageable diagnosis. Your oncologist uses the cell type from your biopsy, the pattern of spread, and any clues from imaging to choose the most likely effective approach. For many patients, the treatment given under a CUP diagnosis is very similar to what would have been given for the most probable primary in any case. Not finding the primary is frustrating, but it does not leave treatment without a direction.

Not necessarily. Finding spread before finding the primary reflects how certain cancers present biologically — it is not always a sign of very late-stage disease. Some CUP presentations carry a meaningfully better outlook than others. Cancer confined to neck lymph nodes, or a presentation in a woman whose cell type suggests an ovarian or breast origin, are examples where the situation differs substantially from other forms of CUP. Your oncologist will explain which pattern fits your situation and what that means for your treatment options.

CT and MRI show anatomy — how structures look. PET shows metabolic activity — which tissues are using energy in the way cancer cells do. A small primary tumour may appear normal on CT but still show abnormal metabolic activity on PET, making it visible for the first time. Combining both in a single PET-CT scan gives the most complete picture available from one appointment. PET-CT is also more likely to find unexpected deposits of spread that change the treatment plan, even in cases where it does not locate the primary.

CION does not own PET-CT scanners. Scans for CION patients are coordinated with four partner PET-CT centres in Hyderabad. Your CION team will arrange the referral and receive the report directly. The scan itself is done at the partner centre; discussion of the results and all treatment decisions happen with your CION oncologist. If you have questions about the report after it comes back, bring them to your oncologist's appointment — the imaging centre is not in a position to advise on treatment.